Invalid Symbol

Stock Research for ABPI

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


ABPI Stock Chart & Research Data

The ABPI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABPI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ABPI Due diligence Resources & Stock Charts

The ABPI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABPI Detailed Price Forecast - CNN Money CNN View ABPI Detailed Summary - Google Finance
Yahoo View ABPI Detailed Summary - Yahoo! Finance Zacks View ABPI Stock Research & Analysis -

Stock Analysis

TradeIdeas View ABPI Trends & Analysis - Trade-Ideas Barrons View ABPI Major Holders - Barrons
NASDAQ View ABPI Call Transcripts - NASDAQ Seeking View ABPI Breaking News & Analysis - Seeking Alpha
Spotlight View ABPI Annual Report - OTC Report View ABPI OTC Short Report -
TradeKing View ABPI Fundamentals - TradeKing Charts View ABPI SEC Filings - Bar Chart
WSJ View Historical Prices for ABPI - The WSJ Morningstar View Performance/Total Return for ABPI - Morningstar
MarketWatch View the Analyst Estimates for ABPI - MarketWatch CNBC View the Earnings History for ABPI - CNBC
StockMarketWatch View the ABPI Earnings - StockMarketWatch MacroAxis View ABPI Buy or Sell Recommendations - MacroAxis
Bullish View the ABPI Bullish Patterns - American Bulls Short Pains View ABPI Short Pain Metrics -

Social Media Mentions

StockTwits View ABPI Stock Mentions - StockTwits PennyStocks View ABPI Stock Mentions - PennyStockTweets
Twitter View ABPI Stock Mentions - Twitter Invest Hub View ABPI Investment Forum News - Investor Hub
Yahoo View ABPI Stock Mentions - Yahoo! Message Board Seeking Alpha View ABPI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ABPI - Insider Cow View Insider Transactions for ABPI - Insider Cow
CNBC View ABPI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABPI - OTC Markets
Yahoo View Insider Transactions for ABPI - Yahoo! Finance NASDAQ View Institutional Holdings for ABPI - NASDAQ

Stock Charts

FinViz View ABPI Stock Insight & Charts - StockCharts View ABPI Investment Charts -
BarChart View ABPI Stock Overview & Charts - BarChart Trading View View ABPI User Generated Charts - Trading View

Latest Financial News for ABPI

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Accentia Biopharmaceuticals Announces that Revimmune™ Autoimmune Disease ...
EON: Enhanced Online News (press release) - May 4, 2011
TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI) today announced that Revimmune™, its proprietary system-of-care based on high-dose administration of Cytoxan® (cyclophosphamide), was featured in an article published in the ...

Stock trades end for two Tampa Bay biopharma firms
Tampa Bay Business Journal (blog) - Jan 19, 2016
The U.S. Securities and Exchange Commission has revoked the securities of two once-promising Tampa Bay biopharmaceutical companies.

Accentia Strikes $1.25M Deal To End Investors' Vaccine Suit
Law360 - Sep 5, 2014
Law360, Miami (September 5, 2014, 7:12 PM EDT) -- An Accentia Biopharmaceuticals Inc. subsidiary agreed Friday to pay $1.25 million to settle a putative securities class action in Florida federal court accusing the company of lying to investors about ...

Biovest Exits Bankruptcy, Appoints New CEO
Twin Cities Business Magazine - Jul 16, 2013
The publicly traded company is a subsidiary of Tampa, Florida-based Accentia Biopharmaceuticals, Inc., and manufactures vaccines, which treat and prevent remission of B-cell non-Hodgkin's lymphoma, a cancer of the immune system.

Enter a stock symbol to view the stock details.